Megan Coylewright, MD, MPH, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Scottsdale Interventional Forum(MODEST), Occlutech(SIGNIFICANT), ACC Cardiosmart(SIGNIFICANT), Boston Scientific(SIGNIFICANT), Abbott(MODEST), Alleviant(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Edwards LifeSciences(SIGNIFICANT), Occlutech(NONE), Medtronic(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Cardiovascular Research Technologies(MODEST)

View Full Disclosure